Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation
Background. Mutations in SLC25A32 in humans cause late-onset exercise intolerance, which is associated with various neurological and metabolic diseases. However, its specific mechanism of action in tumour development is poorly understood owing to the lack of multiomics integrated analysis of SLC25A3...
Saved in:
| Main Authors: | Shiqi Zuo, Siyuan He, Zhiqin Zhu, Yingying Zhang, Yanjie Hou, Ziqing Wu, Yao Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2024/1373659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC
by: Tao Zhou, et al.
Published: (2025-01-01) -
A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01) -
iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
by: Bicheng Ye, et al.
Published: (2025-04-01) -
Multiomics biomarkers were not superior to clinical variables for pan-cancer screening
by: Martin Smelik, et al.
Published: (2024-11-01) -
Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker
by: Ping Yang, et al.
Published: (2025-04-01)